Clinigen Signs Deal With Deciphera to Distribute ROMVIMZA in 29 Markets
Clinigen entered a deal with Deciphera to distribute ROMVIMZA in 29 markets.
Related stories
Altisource Portfolio Reports Third-Quarter Revenue of $51.9 Million
M impact | EQUITY | Oct 29, 2026, 11:27 AM UTC
Blackstone Mortgage Trust Posts Q3 Loss
M impact | EQUITY | Oct 29, 2026, 11:24 AM UTC
DoorDash Q3 Revenue Reaches $4.616 Billion, Net Income $466 Million
DoorDash Q3 revenue was $4.616 billion, versus an IBES estimate of $4.564 billion. Net income was $466 million, compared with an IBES estimate of $388.8 million.
M impact | EQUITY | Oct 29, 2026, 11:23 AM UTC
Spin Master Keeps Annual Guidance Despite Lower Quarterly Revenue
Spin Master reported third-quarter net income of $79 million, or 77 cents a share, while maintaining its guidance for the year despite softer quarterly revenue.
M impact | EQUITY | Oct 29, 2026, 11:22 AM UTC
Verano Reports Lower Q3 2026 Net Loss and Higher Revenue
Verano reported a narrower net loss and higher revenue in the third quarter of 2026.
M impact | EQUITY | Oct 29, 2026, 11:22 AM UTC
Altisource Portfolio Reports $1.4M Third-Quarter Loss
M impact | EQUITY | Oct 29, 2026, 11:22 AM UTC